Search Within

Maria Theodoulou-Haber

Formats
  1. Meeting Abstract (33)
  2. Journal Article (31)
  3. Book Section (1)
  4. Conference Paper (1)
Groups
  1. Department of Medicine (63)
  2. Solid Tumor Oncology Division (63)
  3. Breast Medicine Service (60)
  4. Survivorship Research (58)
  5. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (48)
  6. Epidemiology and Biostatistics (30)

More Groups

People
  1. Clifford Hudis (58)
  2. Larry Norton (45)
  3. Gabriella D'Andrea-Carlino (25)
  4. Tiffany Traina (23)
  5. Andrew Seidman (22)
  6. Monica Fornier (22)

More People

Years
  1. 2019 (1)
  2. 2016 (1)
  3. 2015 (2)
  4. 2014 (2)
  5. 2013 (3)
  6. 2012 (5)

More Years

Publications
  1. Journal of Clinical Oncology (22)
  2. Breast Cancer Research and Treatment (8)
  3. Cancer Research (6)
  4. Clinical Breast Cancer (5)
  5. Clinical Cancer Research (5)
  6. Cancer (3)

More Publications

Publishers
  1. American Society of Clinical Oncology (22)
  2. American Association for Cancer Research (11)
  3. Elsevier Inc. (9)
  4. Springer (8)
  5. Wiley Blackwell (5)
  6. Informa Healthcare (2)

More Publishers

Results (66)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dose-dense therapy with paclitaxel via weekly 1-hour infusion: Preliminary experience in the treatment of metastatic breast cancer
    Conference Paper

    Seidman, A. D.; Hudis, C. A.; McCaffrey, J.; Tong, W.; Currie, V.; Moynahan, M. E.; Theodoulou, M.; Tepler, I.; Gollub, M.; Norton, L.
    Elsevier Inc. (1997)

    Fulltext@MSK | Save
  • Event-free survival after sequential dose-dense doxorubicin (A), paclitaxel (T) and cyclophosphamide (C) in women (pts) with ≥ 4 positive (+) axillary lymph nodes (LN)
    Meeting Abstract

    Hudis, C.; Seidman, A.; Raptis, G.; Baselga, J.; Gilewski, T.; Fennelly, D.; Lebwohl, D.; Surbone, A.; Currie, V.; Moynahan, M.; more...
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save
  • A phase II and pharmacologic study of Taxol (T) by weekly one-hour (1-h) infusion in the treatment of patients (pts) with metastatic breast cancer (MBC)
    Meeting Abstract

    McCaffrey, J. A.; Seidman, A. D.; Tong, W.; Currie, V.; Hudis, C.; Gorman, C.; Moynahan, M.; Theodoulou, M.; Gollub, M.; Norton, L.
    Breast Cancer Research and Treatment (1996)

    Fulltext@MSK | Save
  • Sequential adjuvant therapy: The Memorial Sloan-Kettering Cancer Center experience
    Journal Article

    Hudis, C.; Seidman, A.; Raptis, G.; Fennelly, D.; Gilewski, T.; Baselga, J.; Theodoulou, M.; Sklarin, N.; Moynahan, M.; Surbone, A.; more...
    Seminars in Oncology (1996)

    Fulltext@MSK | Save
  • Rapid hematologic recovery following CD34+ selected versus unselected peripheral blood progenitor cell (PBPC) plus filgrastim (G) rescue of sequential high dose chemotherapy (HDC) in patients (PTS) with metastatic breast cancer (MBC)
    Meeting Abstract

    Raptis, G.; Tiersten, A.; Shapiro, F.; Schneider, J.; Hamilton, N.; Reich, L.; Wuest, D.; Gucciardo, A.; Quiguyan, L.; Gilewski, T.; more...
    Blood (1995)

    Fulltext@MSK | Save
  • Phase II radioimmunotherapy (RIT) trial with I-131 labeled monoclonal antibody CC49 in TAG-72 expressing breast cancer
    Meeting Abstract

    Kostakoglu, L.; Divgi, C. R.; Gilewski, T.; Theodoulou, M.; Schlom, J.; Larson, S. M.
    Journal of Nuclear Medicine (1994)

    Fulltext@MSK | Save